Day: July 2, 2013

What kind of stone maker are you?

Austin Frakt July 2, 2013

Related, I recommend “Cocktail Party Nephrology,” by David Goldfarb. It’s worth a read even if you’re not a stone maker. H/t Karan Chhabra. I make

The monoclonal antibody revolution

Kevin Outterson July 2, 2013

Generic entry for small molecule drugs is controlled by Hatch-Waxman, allowing generic entry 10 – 20 years after FDA approval. For monoclonal antibodies and other

Lucky duckies who are exempt from the individual mandate

Aaron Carroll July 2, 2013

I’ve been working on a talk about the individual mandate and the employer penalty. In preparation, I was taking a look at the HHS “Guidance

Day: July 2, 2013

What kind of stone maker are you?

The monoclonal antibody revolution

Lucky duckies who are exempt from the individual mandate

The Incidental Economist

Editors In Chief

Managing Editor

Subscribe